Phase 2 Locally Advanced Non-Small Cell Lung Cancer trials recruiting now
All Locally Advanced Non-Small Cell Lung Cancer trials, every phase
7
Phase 2 recruiting
Other phases for Locally Advanced Non-Small Cell Lung Cancer
Phase 2 Locally Advanced Non-Small Cell Lung Cancer trials
- Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
- NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
- Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
- Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
- Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
- Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.